“…Azepinone scaffold has been utilized for the formation of constrained dipeptidic moieties such as Aba, 8-hydroxy-4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Hba), and 4-mino-1,2,4,5-tetrahydro-indolo [2,3-c]azepin-3-one (Aia). Replacement of Tic-Gly in Dmt-Tic-Gly analogs with dipeptidic moieties, Aba-Gly and D Aia-Gly, shifted affinity and selectivity to afford a potent MOR agonist and DOR antagonist, respectively [ 283 , 284 , 285 , 286 ]. The same replacement effect was observed in DER tetrapeptide when Phe 3 -Gly 4 was substituted by Aba-Gly [ 287 ].…”